Becton Dickinson (BDX) Curent Deferred Tax Liability (2011 - 2014)
Becton Dickinson's (BDX) quarterly Curent Deferred Tax Liability came in at $10.0 million in Q3 2014, up 25.0% year-on-year from $8.0 million in Q3 2013, and up 25.0% on a QoQ basis from $8.0 million in Q3 2013.
Becton Dickinson (BDX) Curent Deferred Tax Liability (2011 - 2014) Analysis & Trends
Becton Dickinson (BDX) has 4 years of Curent Deferred Tax Liability data on file, last reported at $10.0 million in Q3 2014.
- On a quarterly basis, Curent Deferred Tax Liability rose 25.0% year-over-year to $10.0 million in Q3 2014; TTM through Sep 2014 was $10.0 million, a 25.0% increase from a year earlier, with the FY2014 full-year figure at $10.0 million, up 25.0% from the prior year.
- Curent Deferred Tax Liability for Q3 2014 stood at $10.0 million, up from $8.0 million in the prior quarter.
- Over the last five years, Curent Deferred Tax Liability for BDX reached as high as $10.0 million in Q3 2014 and fell as low as $4.0 million in Q3 2012.
- Historically, Curent Deferred Tax Liability has averaged $7.4 million across 4 years, with a median of $7.8 million in 2011.
- Across the five-year window, Curent Deferred Tax Liability sank 46.82% in 2012 and surged 100.0% in 2013, its largest moves.
- Year by year, Curent Deferred Tax Liability stood at $7.5 million in 2011, then sank by 46.82% to $4.0 million in 2012, then jumped by 100.0% to $8.0 million in 2013, then increased by 25.0% to $10.0 million in 2014.
- Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $10.0 million in Q3 2014, $8.0 million in Q3 2013, and $4.0 million in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 10.00 Mn |
| Sep 30, 2014 | 10.00 Mn |
| Sep 30, 2013 | 8.00 Mn |
| Sep 30, 2013 | 8.00 Mn |
| Sep 30, 2012 | 4.00 Mn |
| Sep 30, 2012 | 4.00 Mn |
| Sep 30, 2011 | 7.52 Mn |
| Sep 30, 2011 | 7.52 Mn |